WELL Health Technologies Corp. (WELL.TO)
| Previous close | 3.7300 |
| Open | 3.7400 |
| Bid | 3.6800 x N/A |
| Ask | 3.7100 x N/A |
| Day's range | 3.6600 - 3.7400 |
| 52-week range | 3.4100 - 5.5500 |
| Volume | |
| Avg. volume | 922,849 |
| Market cap | 904.397M |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | 30.67 |
| EPS (TTM) | 0.1200 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.45 |
GlobeNewswireHEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot
HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD.HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in the American Journal of Kidney Diseases, providing evidence of
- GlobeNewswire
HEALWELL AI Reports Q1-2024 Financial Results
HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132% higher compared to $1.97 million generated in Q1-2023 and 139% higher than $1.92 million generated in Q4-2023.Since its relaunch in Q4-2023 and its acquisition of Intrahealth, an enterprise class EHR service provider on February 1, 2024, the Company’s annual revenue run rate has more than doubled to over $20 million with the largest component of revenues now coming from SaaS and services.Managemen
Simply Wall St.WELL Health Technologies First Quarter 2024 Earnings: Beats Expectations
WELL Health Technologies ( TSE:WELL ) First Quarter 2024 Results Key Financial Results Revenue: CA$231.6m (up 37% from...
